Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02915874 · ClinicalTrials.gov registry record · NA

Does Treating Anxiety Symptoms With ACT Improve Vascular Inflammation and Function?

A NA study of Anxiety, sponsored by University of Iowa.

Completed
Registry status
NA
Development phase
72
Enrollment target
1
Study location

NCT02915874 is a NA study of Anxiety that has completed, run by University of Iowa. The registered enrollment target is 72 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02915874, a NA study of Anxiety, has completed, sponsored by University of Iowa.

COMPLETED
Registry status
NA
Development phase
72 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to evaluate the effectiveness of a brief, intensive 1-day psychotherapy group intervention (Acceptance and Commitment Therapy, ACT), compared to a 12 week time control group on anxiety symptoms, vascular function, inflammation, muscle sympathetic nerve activity (mSNA), and oxidant stress. Similar measures will be performed at baseline in individuals with low or no anxiety for comparison. Individuals who are interested in the study will be identified by an online screening survey and will be contacted by the research team; advertisements, flyers and mass emails will direct individuals to the online screening survey. Those deemed eligible to participate will be randomized to the ACT intervention or a control group. Assessments of anxiety symptoms (via various surveys) and vascular function (via non-invasive, well-established techniques) will be performed at baseline and 12 weeks post-ACT group intervention session. In addition, reassessment of anxiety symptoms via aforementioned surveys will take place 6 weeks post-ACT group session. After 12 weeks, anxiety and vascular assessments will be repeated to re-evaluate severity of anxiety symptoms, vascular function, inflammation, and oxidant stress.

Conditions Studied

Interventions

  • BEHAVIORAL Acceptance and Commitment Therapy

Study Locations (1)

Iowa

  • University of Iowa Hospitals and Clinics - Iowa City

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2014-10
Est. Completion 2017-12
Phase NA

Sponsor

University of Iowa

228 total trials

What the Registry Record Tells You About NCT02915874

The ClinicalTrials.gov registry entry for NCT02915874 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (84% lower). The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Acceptance and Commitment Therapy is the first listed.

NCT02915874 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.

Frequently Asked Questions

What is clinical trial NCT02915874 about?

NCT02915874 is a clinical study titled "Does Treating Anxiety Symptoms With ACT Improve Vascular Inflammation and Function?". The goal of this study is to evaluate the effectiveness of a brief, intensive 1-day psychotherapy group intervention (Acceptance and Commitment Therapy, ACT), compared to a 12 week time control group on anxiety symptoms, vascular function, inflammation, muscle sympathetic nerve activity (mSNA), and ...

What is the current status of trial NCT02915874?

This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2014-10. Estimated completion is 2017-12.

What conditions does trial NCT02915874 study?

This clinical trial studies the following conditions: Anxiety.

What interventions are being tested in trial NCT02915874?

The interventions under investigation include: Acceptance and Commitment Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT02915874?

This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02915874 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.